Sort
130,381 grants matching “hiv”
Cross-species studies of smoking effects on cognition and neuroinflammation in HIV
$881,238Jared William Young · University Of California, San Diego · R01 · FY2017 · DA
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV
$881,222Roger Keith Reeves · Duke University · R01 · FY2021 · AI
Impact of Cannabis on Inflammation and Viral Persistence in Treated HIV/SIV
$881,100Nichole Rose Klatt · University Of Washington · DP1 · FY2016 · DA
Center for Advancing Longtiudinal Drug Abuse Research
$881,025Yih-Ing Hser · University Of California Los Angeles · P30 · FY2010 · DA
Innate, Transcriptomic, and Microbiomic correlates of TB infection
$880,842Michael Haggai Glickman · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI
Designing HIV-1 envelope immunogens to maximize neutralization breadth through use of multiple founder envelope antigens
$880,838Sandhya Vasan · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2024 · AI
Biology and Therapy of Lymphopenia
$880,808Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
In vivo hematopoietic stem cell engineering for HIV cure
$880,758Hans-Peter Kiem · University Of Southern California · P01 · FY2025 · HL
Genetic Epidemiology of Complex Traits
$880,653Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2011 · HG
Targeting PD-1 Pathway for Functional Cure of AIDS
$880,613Rama Rao Amara · Emory University · R01 · FY2025 · AI
Husbandry & Management Core
$880,595Gregory Brion Timmel · University Of California At Davis · U42 · FY2025 · OD
Building on Needle Exchange to Optimize HIV Prevention/Treatment
$880,508Gregory M Lucas · Johns Hopkins University · R01 · FY2018 · DA
Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens
$880,342Beatrice H Hahn · University Of Pennsylvania · R37 · FY2019 · AI
Determining the effects of broadly neutralizing antibodies at antiretroviral therapy initiation
$880,331Katharine June Bar · University Of Pennsylvania · R01 · FY2023 · AI
Essential Logistic Needs to Implement the C.L.E.A.R. Phase-I HIV Vaccine Trial
$880,288Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Novel pre-coital, non-hormonal multipurpose prevention technology (MPT)
$880,230Pavimol Angsantikul · Population Council · R01 · FY2022 · AI
AIDS RESEARCH CORE
$880,139Yamamura Yasuhiro · Ponce School Of Medicine · G12 · FY2009 · RR
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors
$880,000Michael Emerman · Fred Hutchinson Cancer Center · DP1 · FY2022 · DA
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION
$880,000Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2017 · DA
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors
$880,000Michael Emerman · Fred Hutchinson Cancer Research Center · DP1 · FY2021 · DA
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors
$880,000Michael Emerman · Fred Hutchinson Cancer Research Center · DP1 · FY2020 · DA
SUPPORTING THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE
$880,000Peter Savosnick · Elizabeth Glaser Pediatric Aids Fdn · U2G · FY2010 · PS
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION
$880,000Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2019 · DA
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors
$880,000Michael Emerman · Fred Hutchinson Cancer Center · DP1 · FY2024 · DA
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION
$880,000Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2015 · DA